Treatment Plan for Acute Gout Attack in Patient on Allopurinol
Continue allopurinol 100 mg daily without interruption and immediately initiate anti-inflammatory therapy with an NSAID, colchicine, or corticosteroid to treat the acute attack. 1
Acute Attack Management
First-Line Anti-Inflammatory Options (Choose One Based on Comorbidities)
NSAIDs: Initiate any potent NSAID at full anti-inflammatory doses immediately, as the most critical determinant of success is how rapidly treatment begins, not which specific NSAID is selected 2, 3
Colchicine: Use 0.5-1.0 mg daily as an alternative if NSAIDs are contraindicated 4
Corticosteroids: Reasonable choice for patients in whom both colchicine and NSAIDs are hazardous or previously not tolerated 2
- Prednisone/prednisolone 30-40 mg daily or equivalent
- Consider intra-articular injection for monoarticular involvement
Critical Management of Allopurinol During Acute Attack
Continue Current Allopurinol Dose
- Do not stop or reduce allopurinol 100 mg daily - modern evidence demonstrates that continuing urate-lowering therapy during acute attacks does not prolong the flare when adequate anti-inflammatory prophylaxis is provided 6
- A randomized controlled trial showed no statistically significant difference in days to resolution when allopurinol was continued (15.4 days) versus placebo (13.4 days, p=0.5) 6
Do Not Increase Allopurinol Dose During Acute Attack
- Maintain the current 100 mg daily dose until the acute attack fully resolves 1
- Rapid increases in allopurinol dosing can precipitate or prolong acute attacks 1
Post-Attack Allopurinol Optimization Plan
Dose Titration Strategy (After Attack Resolves)
- Week 0-4: Continue allopurinol 100 mg daily with prophylaxis 1
- Week 4: Increase to 200 mg daily if serum uric acid remains >6 mg/dL 1
- Week 8: Increase to 300 mg daily if needed to achieve target <6 mg/dL 1
- Continue titration: Increase by 100 mg increments at 2-4 week intervals until serum uric acid <6 mg/dL is achieved, up to maximum 800 mg daily 1
Target Serum Uric Acid
- Standard target: <6 mg/dL (360 μmol/L) for all patients 7, 1
- Lower target: <5 mg/dL (300 μmol/L) for patients with tophi, chronic arthropathy, or frequent attacks until crystal dissolution is complete 5, 7
Mandatory Prophylaxis During Dose Titration
Prophylactic Therapy Requirements
- Initiate prophylaxis immediately with colchicine 0.5-1.0 mg daily OR an NSAID (with gastroprotection if indicated) 4, 5
- Duration: Continue for minimum 3-6 months after initiating or increasing allopurinol 4, 5
- Extend prophylaxis beyond 6 months if patient continues experiencing flares 5
- The number needed to treat with colchicine prophylaxis is 2, meaning one in two patients will be prevented from experiencing an attack 4
Prophylaxis Monitoring
- Colchicine causes significantly more diarrhea than placebo (RR=8.38) 4
- Monitor for neurotoxicity with long-term colchicine use 4
- Adjust colchicine dose for renal function as noted above 5
Supportive Measures
- Hydration: Maintain fluid intake sufficient to yield ≥2 liters daily urinary output 1
- Urine pH: Maintain neutral or slightly alkaline urine to prevent xanthine calculi and urate precipitation 1
- Lifestyle: Apply topical ice and rest the affected joint during acute attack 3
- Timing: Consider taking allopurinol after meals to minimize gastric irritation 1
Common Pitfalls to Avoid
- Never discontinue allopurinol during an acute attack when the patient is already on therapy - this is outdated practice 6
- Never start allopurinol dose escalation during an acute attack - wait until complete resolution 1
- Never initiate or increase allopurinol without prophylaxis - this significantly increases flare risk 4, 5
- Never rely solely on 100 mg or 300 mg "standard doses" - titrate to achieve serum uric acid target <6 mg/dL 7, 1
- Never stop prophylaxis prematurely (<3 months) as this increases risk of recurrent flares 5
Monitoring Schedule
- During acute attack: Assess response to anti-inflammatory therapy every 2-3 days
- After attack resolution: Check serum uric acid 2-4 weeks after each dose adjustment 1
- Long-term: Monitor serum uric acid every 6 months once target is achieved 7
- Renal function: Monitor BUN and creatinine periodically, especially in patients with pre-existing renal disease 1